Loading clinical trials...
Loading clinical trials...
Phase I/II Study of NORTHERA (DROXIDOPA) for Dysautonomia in Adult Survivors of Menkes Disease and Adults With Occipital Horn Syndrome: Double-blind Placebo-controlled Randomized Crossover Clinical Trial
Conditions
Interventions
Droxidopa
Placebo
Locations
1
United States
Vagelos College of Physicians and Surgeons, Columbia University
New York, New York, United States
Start Date
July 12, 2021
Primary Completion Date
October 30, 2023
Completion Date
June 29, 2024
Last Updated
September 16, 2025
Lead Sponsor
Stephen G. Kaler, MD
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions